1 completed, 1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Placebo plus MTX: new trials by email Literature Review of Placebo plus MTX trials Research Report on Placebo plus MTX
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects with Inadequate Response to MTX Due to Treat Moderate and Severe Rheumatoid Arthritis. Placebo plus MTX, RC18 160 mg plus MTX - Moderate and Severe RheumatoId Arthritis | Phase 3 | Completed | RemeGen Co., Ltd. | 479 | 2017-03-29 | 2024-09-26 |
| A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Inadequate Response to TNF-α Antagonists Due to Treat Moderate and Severe Rheumatoid Arthritis Placebo plus MTX, RC18 160 mg plus MTX - Moderate and Severe Rheumatoid Arthritis | Phase 2 | Terminated | RemeGen Co., Ltd. | 60 | 2015-10-01 | 2019-04-03 |
Arthritis, Rheumatoid (2) · Lymphoma, Follicular (2)
China (2)
Chunde Bao (1) · Fengchun Zhang (1)